//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Arzneimittel"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"RIX4414"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Arzneimittel
Cost savings
3
Economic evaluation
3
Germany
3
Paediatric
3
RIX4414
3
Rotavirus
3
Vaccination
3
Adis-Drug-Evaluations
1
Children
1
Coronavirus
1
Deutschland
1
Gastroenteritis
1
Gesundheitskosten
1
Health care costs
1
Impfung
1
Infants
1
Infectious disease
1
Infektionskrankheit
1
Pharmaceuticals
1
RIX-4414
1
Rotavirus-infections
1
prevention
1
therapeutic use
1
more ...
less ...
Online availability
All
Free
1
Type of publication
All
Article
1
Type of publication (narrower categories)
All
Article in journal
1
Aufsatz in Zeitschrift
1
Language
All
English
1
Author
All
Benter, Ursula
1
Knoll, Stefanie
1
Mair, Christoph
1
Standaert, Baudouin
1
Vouk, Katja
1
Published in...
All
Health economics review
1
Source
All
ECONIS (ZBW)
1
Showing
1
-
1
of
1
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Will vaccination against rotavirus infection with
RIX
4414
be cost-saving in Germany?
Knoll, Stefanie
;
Mair, Christoph
;
Benter, Ursula
;
Vouk, …
- In:
Health economics review
3
(
2013
)
27
,
pp. 1-11
whether rotavirus vaccination using the two-dose rotavirus vaccine
RIX
4414
(Rotarix®, GlaxoSmithKline Vaccines) would be a …
Persistent link: https://www.econbiz.de/10010242226
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->